Bayer CropScience Ltd

Q4 FY21Fertilizers & Agrochemicals

Bayer CropScience Q4 FY21 earnings call: Revenue & Margins

Q4 FY21 investor presentation: what the company reported on revenue, margins and projects.

Price₹3,736

Market cap₹17.0K Cr

P/E23.2

Updated24 Sept 2026

Read4 min read

Based on Bayer CropScience Ltd's Q4 FY21 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) - Q4 2020-21 Profit Before Exceptional Items and Tax: ₹735 million, up 20% YoY (Page 10) - Full Year (FY) 2020-21 Revenue f Q4 EBITDA before exceptional items: ₹7,337 million, up 20% YoY (Page 10) - Q4 Revenue from operations: ₹42,613 million, up 18% YoY (Page 10) - Q4 Profit Before Exceptional Items and Tax: ₹7,894 mi

From Bayer CropScience Ltd's Q4 FY21 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

- Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) - Q4 2020-21 Profit Before Exceptional Items and Tax: ₹735 million, up 20% YoY (Page 10) - Full Year (FY) 2020-21 Revenue from Operations: ₹42,613 million, up 18% YoY (Page 10) - FY 2020-21 Profit Before Exceptional Items and Tax: ₹7,894 million, up 11% YoY (Page 10) - Crop Science segment Q1 2021 sales: €12,328 million, +3% adjusted for currency and portfolio effects (Page 8) - EBITDA before Special items Q1 2021: €4,118 million, down 6% (Page 8) Explicit Outlook:

2 more points management made on revenue & sales performance

Profitability & Margins

Q4 EBITDA before exceptional items: ₹7,337 million, up 20% YoY (Page 10)
Q4 Revenue from operations: ₹42,613 million, up 18% YoY (Page 10)
Q4 Profit Before Exceptional Items and Tax: ₹7,894 million, up 11% YoY (Page 10)
Operating profit before working capital changes for the year ending Mar 31, 2021: ₹8,566 million (Page 12)
Net cash from operating activities for the year ended Mar 31, 2021: ₹6,867 million (Page 12)

2 more points management made on profitability & margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation provided does not explicitly mention any capex amounts, capacity expansions, new plants, or specific project details including status or timelines. The focus is primarily on financial performance, COVID-19 response, digital initiatives, integration synergies, market outlook, and smallholder impact assessments. No direct references to capital expenditure, capacity expansion plans, or new project investments are included in the slides from pages 1 to 21.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹211 Cr

Rev 2Mar 1

2Dharmaj Crop₹998 Cr

Rev 2Mar 2

3₹7.4K Cr

Rev 2Mar 3

4₹5.8K Cr

Rev 2Mar 3

5₹1.3K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation does not explicitly mention any fundraising through debt or equity.
Page 12 (Cash Flow) shows net cash from financing activities as (5,558) million INR for the year ended 31-Mar-21, which suggests net repayments or outflows rather than new borrowings.
Page 11 (Balance Sheet) does not detail borrowings or debt explicitly but shows strong cash and equivalents of 12,045 million INR as of 31-Mar-21.

2 more points management made on fundraising & capital structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report specific figures or detailed data regarding order book, order inflow, or pending orders. However, the following relevant points are mentioned: - Growth in Crop Protection driven by Vegetables, Rice & Apple and pre-orders of Roundup (RUP) (Page 16). - Importance of on-time & last-mile availability at retail points this season, with limited opportunity for amendments (Page 15).

2 more points management made on order book & pipeline

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Bayer CropScience Ltd's management said in earlier quarters

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bayer CropScience Ltd Q4 FY21 results?

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bayer CropScience Ltd planning capital expenditure?

The investor presentation provided does not explicitly mention any capex amounts, capacity expansions, new plants, or specific project details including status or timelines.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.